SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
Quick Stats
Feb 02, 202661.7
AI Score
BUY1.48
Volume Ratio
Nov 19, 2025
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
SABS Stock Summary
Last updated Feb 02, 2026
SABS is currently trading at $4.38, positioned above its 200-day moving average of $2.64, indicating a long-term uptrend. The stock has a 52-week range of $1 to $6.6.
Technical Analysis: The 50-day moving average stands at $3.91, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 67.752, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.03, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates SABS at 61.7/100 with a BUY recommendation.
SABS (SAB Biotherapeutics, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 67.752 |
| CMF (20) | -0.03 |
| ROC (10) | 10.05 |
| ADX (14) | 17.697 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.162 |
| AROONOSC (14) | 100.0 |
| WILLAMS %R (14) | -30.0 |
| MFI (14) | 75.524 |
SABS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
SABS Price vs Max Options Open Interest
SABS Max Change In Options Open Interest
SABS Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SABS Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SABS Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SABS Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SAB Biotherapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
SABS Moving Averages Analysis
SAB Biotherapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026
SAB Biotherapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
SABS (SAB Biotherapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 4.21 |
| 20 | 4.03 |
| 30 | 3.96 |
| 50 | 3.91 |
| 100 | 3.28 |
| 200 | 2.64 |
SABS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 209.0 million |
| Earnings/Share ($) | -1.54 |
| Net Proft Margin (%) | 163.3832 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1 |
| EPS Estimate Next Year ($) | -0.3 |
| WallStreet Target Price ($) | 9.375 |
| Most Recent Quarter |